Self-reported adverse events associated with ∆(8)-Tetrahydrocannabinol (Delta-8-THC) Use

BACKGROUND: There is an expanding unregulated market for a psychotropic compound called ∆(8)-Tetrahydrocannabinol (delta-8-THC) that is being derived from hemp, but a summary of adverse events related to delta-8-THC has not been publicly reported. METHODS: This case series assessed adverse events re...

Descripción completa

Detalles Bibliográficos
Autores principales: Leas, Eric C., Harati, Raquel M., Satybaldiyeva, Nora, Morales, Nicolas E., Huffaker, Shelby L., Mejorado, Tomas, Grant, Igor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204335/
https://www.ncbi.nlm.nih.gov/pubmed/37217977
http://dx.doi.org/10.1186/s42238-023-00191-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204335/
https://www.ncbi.nlm.nih.gov/pubmed/37217977
http://dx.doi.org/10.1186/s42238-023-00191-y

Ejemplares similares